We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.76%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$13.8B
AUM Growth
-$581M
Cap. Flow
-$2.79B
Cap. Flow %
-20.16%
Top 10 Hldgs %
25.18%
Holding
905
New
29
Increased
148
Reduced
448
Closed
194

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$66.4M
2
VLO icon
Valero Energy
VLO
+$28.9M
3
SLB icon
SLB Ltd
SLB
+$24.8M
4
BNY
Bank of New York Mellon
BNY
+$22.6M
5
PEP icon
PepsiCo
PEP
+$20.4M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$182M
2
AAPL icon
Apple
AAPL
+$148M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$90.9M
4
AMGN icon
Amgen
AMGN
+$72.1M
5
TSLA icon
Tesla
TSLA
+$66.1M

Sector Composition

Rank Sector Weight
1 Healthcare 31.26%
2 Technology 28.78%
3 Financials 8.15%
4 Consumer Discretionary 7.54%
5 Industrials 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAP icon
676
Advance Auto Parts
AAP
$3.37B
– –
-3,338
Closed -$374K
ACM icon
677
Aecom
ACM
$9.07B
– –
-7,500
Closed -$582K
ACRS icon
678
Aclaris Therapeutics
ACRS
$730M
– –
-55,208
Closed -$411K
ADV icon
679
Advantage Solutions
ADV
$484M
– –
-9,360
Closed -$340K
AGIO icon
680
Agios Pharmaceuticals
AGIO
$2.16B
– –
-20,160
Closed -$426K
AGO icon
681
Assured Guaranty
AGO
$3.78B
– –
-52,157
Closed -$2.41M
ALEC icon
682
Alector
ALEC
$164M
– –
-68,368
Closed -$390K
ALLK
683
DELISTED
Allakos
ALLK
– –
-82,313
Closed -$337K
ALLY icon
684
Ally Financial
ALLY
$13.1B
– –
-50,963
Closed -$1.2M
AMC icon
685
AMC Entertainment Holdings
AMC
$2.03B
– –
-8,229
Closed -$379K
AMH icon
686
American Homes 4 Rent
AMH
$12B
– –
-17,886
Closed -$518K
AMG icon
687
Affiliated Managers Group
AMG
$9.46B
– –
-19,008
Closed -$2.49M
ANAB icon
688
AnaptysBio
ANAB
$1.6B
– –
-20,205
Closed -$405K
ANGO icon
689
AngioDynamics
ANGO
$562M
– –
-39,009
Closed -$371K
APA icon
690
APA Corp
APA
$12.8B
– –
-15,184
Closed -$504K
AQN icon
691
Algonquin Power & Utilities
AQN
$4.69B
– –
-39,348
Closed -$303K
ARCT icon
692
Arcturus Therapeutics
ARCT
$157M
– –
-29,401
Closed -$649K
ARW icon
693
Arrow Electronics
ARW
$10.9B
– –
-3,465
Closed -$398K
ATRA icon
694
Atara Biotherapeutics
ATRA
$71.2M
– –
-5,846
Closed -$390K
AVIR icon
695
Atea Pharmaceuticals
AVIR
$379M
– –
-135,316
Closed -$417K
AXS icon
696
AXIS Capital
AXS
$8.59B
– –
-48,361
Closed -$2.43M
AYI icon
697
Acuity Brands
AYI
$9.88B
– –
-32,524
Closed -$5.47M
AZTA icon
698
Azenta
AZTA
$1.26B
– –
-39,051
Closed -$1.6M
BCC icon
699
Boise Cascade
BCC
$2.74B
– –
-19,806
Closed -$1.15M
BCAB icon
700
BioAtla
BCAB
$5.59M
– –
-31,308
Closed -$3.86M
26 27
28
29 30

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2023 Portfolio in Review

As of Q2 2023, Candriam SCA held 905 positions worth $13.8B, down 4% from $14.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Candriam SCA withdrew a net $2.79B in Q2 2023, closing 194 positions and reducing 448 holdings. Its most notable exit was Thomson Reuters, an estimated $19.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in Vir Biotechnology worth $8.7M.

  • Candriam SCA's largest Q2 2023 buy was Vir Biotechnology: 354,645 shares worth $8.7M.
  • Candriam SCA added most to Lam Research in Q2 2023, an estimated $66.4M increase.
  • Candriam SCA's biggest Q2 2023 reduction was Microsoft, cutting an estimated $182M.
  • Candriam SCA fully exited Thomson Reuters in Q2 2023, selling an estimated $19.8M.
  • Candriam SCA's ten largest holdings make up 25% of its $13.8B portfolio in Q2 2023.
  • Candriam SCA opened 29 new positions and closed 194 in Q2 2023.
  • Candriam SCA's portfolio value fell 4% quarter-over-quarter to $13.8B.

Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.